Science Explorer Back to mapMap
Institution · Baptist Cancer Center

Most cited papers from Baptist Cancer Center

What are the most cited papers from Baptist Cancer Center?

The most cited paper from Baptist Cancer Center is "Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study" (Jedd D. Wolchok, Bart Neyns, Gerald P. Linette et al., 2009), with 1,198 citations. Next come "Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease" (908) and "Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial" (872).

Showing 50 of 60 papers. Every paper with more than 39 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study Jedd D. Wolchok, Bart Neyns, Gerald P. Linette et al. · The Lancet Oncology 9 Dec 2009 1,198
2 Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease Kenneth I. Ataga, Abdullah Kutlar, Julie Kanter et al. · New England Journal of Medicine Open access 3 Dec 2016 908
3 Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial David J. Kuter et al. · The Lancet Feb 2008 872
4 American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline Carolyn D. Runowicz, Corinne R. Leach, N. Lynn Henry et al. · CA A Cancer Journal for Clinicians Open access 7 Dec 2015 752
5 Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial William D. Tap, Robin L. Jones, Brian Andrew Van Tine et al. · The Lancet Open access 12 Jun 2016 595
6 Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer Jeffrey D. Bradley, Chen Hu, Ritsuko R. Komaki et al. · Journal of Clinical Oncology Open access 16 Dec 2019 594
7 Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer Bernard Fisher, James J. Dignam, Birol Emir et al. · JNCI Journal of the National Cancer Institute 19 Nov 1997 527
8 Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules Morad K. Nakhleh et al. · ACS Nano Open access 21 Dec 2016 507
9 Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium Petros D. Grivas et al. · Annals of Oncology Open access128 authors 19 Mar 2021 327
10 Rural–Urban Disparities in Cancer Outcomes: Opportunities for Future Research Smita Bhatia, Wendy Landier, Electra D. Paskett et al. · JNCI Journal of the National Cancer Institute Open access 4 Feb 2022 324
11 National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide Bronwen E. Shaw et al. · Journal of Clinical Oncology Open access 27 Apr 2021 221
12 Silicon Nanowire Sensors Enable Diagnosis of Patients via Exhaled Breath Nisreen Shehada, John C. Cancilla, José S. Torrecilla et al. · ACS Nano 6 Jul 2016 221
13 Leukocytosis: basics of clinical assessment. Neil Remington Abramson, Becky Melton · PubMed Nov 2000 215
14 Benign Metastasizing Leiomyoma Simeon Abramson, Robert Gilkeson, Jeffrey D. Goldstein et al. · American Journal of Roentgenology Jun 2001 193
15 Quality of Life Analysis of a Radiation Dose–Escalation Study of Patients With Non–Small-Cell Lung Cancer Benjamin Movsas, Chen Hu, Jeffrey A. Sloan et al. · JAMA Oncology Open access 25 Nov 2015 183
16 Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: The Memphis experience Kevin Thomas Robbins, Parvesh Kumar, William F. Regine et al. · International Journal of Radiation Oncology*Biology*Physics May 1997 168
17 Three-dimensional treatment planning of intracavitary gynecologic implants: Analysis of ten cases and implications for dose specification Sonja L. Schoeppel, Mark L. Lavigne, Mary K. Martel et al. · International Journal of Radiation Oncology*Biology*Physics Open access 1994 159
18 Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials Joseph M. Unger, Anna B. Moseley, Christabel K. Cheung et al. · Journal of Clinical Oncology Open access 17 Mar 2021 151
19 Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond Uyiosa Osarogiagbon, Obiageli Uchenna Ogbata, Xinhua Yu · The Annals of Thoracic Surgery Open access 21 Nov 2013 139
20 The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies Benjamin Movsas, Charles Scott, William T. Sause et al. · International Journal of Radiation Oncology*Biology*Physics Dec 1999 126
21 Risk Factors for Ischemic Complications following Pipeline Embolization Device Treatment of Intracranial Aneurysms: Results from the IntrePED Study Waleed Brinjikji, Giuseppe S Lanzino, Harry J. Cloft et al. · American Journal of Neuroradiology Open access 21 Apr 2016 123
22 Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: Results of two randomized double blind controlled multiinstitutional trials Aman U. Buzdar, Robert A. Smith, Charles L. Vogel et al. · Cancer 15 Jun 1996 119
23 Prospective study on embolization of intracranial aneurysms with the pipeline device (PREMIER study): 3-year results with the application of a flow diverter specific occlusion classification Ricardó A. Hanel et al. · Journal of NeuroInterventional Surgery Open access 15 Mar 2022 105
24 Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database Yolanda D. Tseng, Hajime Uno, Melissa E. Hughes et al. · International Journal of Radiation Oncology*Biology*Physics 11 Jul 2015 99
25 Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma Martin M. Oken, David P. Harrington, Neil Remington Abramson et al. · Cancer 15 Apr 1997 98
26 Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial Ulrich Keilholz, Janice M. Mehnert, Sebastian Bauer et al. · Journal for ImmunoTherapy of Cancer Open access 16 Jan 2019 82
27 Pretreatment18F-FDG PET Textural Features in Locally Advanced Non–Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235 Nitin Ohri, Fenghai Duan, Bradley S. Snyder et al. · Journal of Nuclear Medicine Open access 11 Feb 2016 81
28 American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism Mark Zafereo, Justin Yu, Peter Angelos et al. · Head & Neck 19 Apr 2019 80
29 Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer Stephen C. Lam, Chunxue Bai, David R. Baldwin et al. · Journal of Thoracic Oncology Open access 23 Jul 2023 78
30 Anesthesia Duration as an Independent Risk Factor for Postoperative Complications in Free Flap Surgery: A Review of 1,305 Surgical Cases David J.W. Grant, Bobby Kim, Jon Ver Halen et al. · Journal of Reconstructive Microsurgery 25 Oct 2013 78
31 Bispecific Antibodies in the Treatment of Hematologic Malignancies Johannes Duell, Philip Edward Lammers, Ivana M. Djuretic et al. · Clinical Pharmacology & Therapeutics Open access 16 Feb 2019 77
32 Pretreatment FDG-PET Metrics in Stage III Non-Small Cell Lung Cancer: ACRIN 6668/RTOG 0235 Nisha Ohri, Fenghai Duan, Mitchell X. Machtay et al. · JNCI Journal of the National Cancer Institute Open access 16 Feb 2015 76
33 Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database Mark W. Onaitis, Anthony P. Furnary, Andrzej Stanislaw Kosinski et al. · The Annals of Thoracic Surgery 22 Nov 2017 70
34 Differential effects of operative complications on survival after surgery for primary lung cancer Félix G. Fernández, Andrzej Stanislaw Kosinski, Anthony P. Furnary et al. · Journal of Thoracic and Cardiovascular Surgery Open access 13 Nov 2017 70
35 Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer Lisa Ann Kachnic, Kathryn A Winter, Robert J. Myerson et al. · International Journal of Radiation Oncology*Biology*Physics Open access 13 Aug 2021 65
36 Management of pterygium with surgery and radiation therapy Shyam B. Paryani, Walter P. Scott, JOHN W. WELLS et al. · International Journal of Radiation Oncology*Biology*Physics Open access 1994 64
37 Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer Matthew P. Smeltzer, Nicholas Ryan Faris, Xinhua Yu et al. · The Annals of Thoracic Surgery Open access 3 Jun 2016 63
38 Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group 9513 Barbara C. Fisher, Minhee Won, David Robert Walker MacDonald et al. · International Journal of Radiation Oncology*Biology*Physics Jul 2002 62
39 Impact of Guideline Changes on Use or Omission of Radiation in the Elderly with Early Breast Cancer: Practice Patterns at National Comprehensive Cancer Network Institutions Beryl L. McCormick, Rebecca A. Ottesen, Melissa E. Hughes et al. · Journal of the American College of Surgeons 7 Jun 2014 62
40 Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma Asim Amin, David H. Lawson, April K.S. Salama et al. · Journal for ImmunoTherapy of Cancer Open access 22 Jul 2016 61
41 Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216) Kenneth L. Kehl, David M. Zahrieh, Ping Yang et al. · JAMA Oncology Open access 17 Mar 2022 57
42 Assessing Safety and Outcomes in Outpatient versus Inpatient Thyroidectomy using the NSQIP: A Propensity Score Matched Analysis of 16,370 Patients Nima Khavanin, Alexei S. Mlodinow, John Y. S. Kim et al. · Annals of Surgical Oncology 19 May 2014 57
43 Platelet Testing is Associated with Worse Clinical Outcomes for Patients Treated with the Pipeline Embolization Device Waleed Brinjikji, Giuseppe S Lanzino, Harry J. Cloft et al. · American Journal of Neuroradiology Open access 6 Aug 2015 57
44 Mastering Communication with Seriously Ill Patients: Balancing Honesty with Empathy and Hope Neil Remington Abramson · Annals of Internal Medicine 3 Nov 2009 56
45 Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial Bronwen E. Shaw et al. · Transplantation and Cellular Therapy Open access 27 Dec 2022 55
46 Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer Mark W. Onaitis, Anthony P. Furnary, Andrzej Stanislaw Kosinski et al. · The Annals of Thoracic Surgery 29 Feb 2020 54
47 Angioplasty and stenting for symptomatic extracranial non-tandem internal carotid artery occlusion Ashutosh Prabhakar Jadhav, David Michael Panczykowski, Mouhammad A. Jumaa et al. · Journal of NeuroInterventional Surgery 29 Apr 2018 53
48 Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists Kathryn Finch Mileham, Caroline Schenkel, Suanna S. Bruinooge et al. · Cancer Medicine Open access 17 Dec 2021 52
49 Variations in Receipt of Curative-Intent Surgery for Early-Stage Non–Small Cell Lung Cancer (NSCLC) by State Helmneh M. Sineshaw, Xiao‐Cheng Wu, W. Dana Flanders et al. · Journal of Thoracic Oncology Open access 12 Mar 2016 51
50 Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials Renata Ferrarotto, Ian C. Anderson, Balazs Medgyasszay et al. · Cancer Medicine Open access 18 Aug 2021 50

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.